Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration
Clinical trial NCT04919096 · WITHDRAWN
Trial details
- NCT number
- NCT04919096
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2022-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.